Deal postponed: Grifols SA’s acquisition of Talecris Biotherapeutics Holdings Corp.
The closing date for Spanish healthcare company Grifols SA’s acquisition of North Carolina-based Talecris Biotherapeutics Holdings Corp. has been extended until June 30, according to a report in BusinessWeek.
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: